title: Cytotoxic T-lymphocyte and NK responses in mice treated prenatally with chlordane.
abstract: It has been reported previously that BALB/c mice, treated in utero with chlordane, showed increased survival to influenza A/PR/8/34 [H1N1] (influenza) virus as young adults. To determine the possible role of cell-mediated immunity (CMI) on this effect, cytotoxic T-lymphocyte (CTL) and natural killer (NK) cell activities were assessed on chlordane-exposed offspring at 100 and 200 days post partum. The CTL response of these offspring showed no significant change from that obtained from their sex- and age-matched control counterparts exposed prenatally to the vehicle. NK responses of chlordane-exposed female offspring were significantly higher at 100 days of age but not at 200 days of age. Although male offspring that were exposed to chlordane prenatally showed no difference in NK cell activity at 100 days of age, NK cell activity was significantly less in chlordane-treated animals than controls at 200 days of age. Thus, prenatal treatment of mice with chlordane had varying effects on the NK cell activity of adult offspring, depending on the sex and age of the animal. It is concluded that the previously reported increase in survival to influenza is due to a resolution of the infection by normal CTL and NK cell activities coupled with a decrease in delayed-type hypersensitivity (DTH)-mediated pathology.
authors.affiliation: Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock 72205.
authors.forename: B L
authors.initials: BL
authors.lastname: Blaylock
authors.forename: L S
authors.initials: LS
authors.lastname: Soderberg
authors.forename: J
authors.initials: J
authors.lastname: Gandy
authors.forename: J H
authors.initials: JH
authors.lastname: Menna
authors.forename: R
authors.initials: R
authors.lastname: Denton
authors.forename: J B
authors.initials: JB
authors.lastname: Barnett
mesh_terms: D000367:Age Factors; D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D002706:Chlordan / Q000008:administration & dosage / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D005260:Female; D007111:Immunity, Cellular / Q000187:drug effects; D007694:Killer Cells, Natural / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D008297:Male; D051379:Mice; D009976:Orthomyxoviridae Infections / Q000276:immunology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D012737:Sex Factors; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects* / Q000276:immunology / Q000473:pathology
chemical_list: D002706:Chlordan